Physician profile
Anthony R Sergi
NPI 1972597482
$4,840.46
in general payments reported to CMS, 2019-2025
38 companies · $862 in 2025
The $862 reported for 2025 was more than what 77% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $910 · 2020: $481 · 2021: $823 · 2022: $576 · 2023: $700 · 2024: $488 · 2025: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,050.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $788.32 | 2019-2022 | |
| Stryker Corporation | $752.11 | 2019-2025 | Asnis, Easyfuse, Ortholoc 3di Crosscheck |
| Paratek Pharmaceuticals, INC. | $536.56 | 2021-2025 | Nuzyra |
| Horizon Therapeutics Plc | $274.90 | 2019-2021 | |
| Smith+Nephew, INC. | $270.34 | 2020-2025 | Grafix Pl, Collagenase Santyl, Regranex |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $248.51 | 2019-2025 | Jublia |
| Treace Medical Concepts, INC. | $215.63 | 2022-2025 | |
| Zyla Life Sciences, INC. | $164.10 | 2019 | |
| Zimmer Biomet Holdings, INC. | $157.20 | 2020-2022 | |
| Depuy Synthes Sales INC. | $138.97 | 2019-2025 | Motoband |
| Sebela Pharmaceuticals INC. | $126.58 | 2019-2023 | Naftin |
| Musculoskeletal Transplant Foundation INC. | $104.99 | 2019-2025 | |
| Amgen INC. | $99.36 | 2024-2025 | Krystexxa |
| Globus Medical, INC. | $93.47 | 2023-2025 | Ankle Fracture System, Senza |
| Integra Lifesciences Corporation | $87.85 | 2019-2020 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $66.20 | 2021 | |
| Orthofix Medical, INC. | $64.81 | 2024-2025 | Physio-Stim |
| Merck Sharp & Dohme LLC | $62.22 | 2019 | |
| Nabriva Therapeutics, Plc | $55.59 | 2021-2022 | |
| Tenex Health INC. | $49.84 | 2019 | |
| Nevro Corp. | $48.22 | 2022-2024 | Senza |
| Medtronic, INC. | $43.58 | 2022-2025 | Inceptiv |
| Medshape, INC. | $37.87 | 2023 | Dynanail Hybrid |
| Averitas Pharma INC. | $36.85 | 2024-2025 | Qutenza |
| Vertex Pharmaceuticals Incorporated | $36.78 | 2025 | |
| Bone Support INC. | $33.85 | 2025 | Cerament G, Ceramentbone Void Filler |
| Convatec INC. | $32.91 | 2023 | |
| Kerecis Limited | $29.59 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Grt US Holding, INC. | $29.22 | 2022 | |
| Davol INC. | $26.49 | 2024 | Arista Ah Flexitip |
| Seapearl East, INC | $20.41 | 2024 | |
| Medtronic USA, INC. | $19.61 | 2020 | |
| Bioventus LLC | $17.12 | 2023 | Exogen Ultrasound Bone Healing System |
| Paragon 28, INC. | $15.54 | 2021 | |
| Journey Medical Corporation | $14.24 | 2020 | |
| Ibsa Pharma INC. | $14.04 | 2023 | Tirosint, Licart |
| Baudax Bio INC. | $13.93 | 2020 | |
| Alfasigma USA, INC. | $12.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Sergi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.